Evolution in the diagnostic approach to lung cancer

J. Da Silva Arana Fonseca Ribeiro (Guarda, Portugal), G. Samouco (Guarda, Portugal), R. Martins Natal (Guarda, Portugal), S. Braga (Guarda, Portugal), F. Luís (Guarda, Portugal), L. Ferreira (Guarda, Portugal), R. Matos Gomes (Guarda, Portugal), L. Vaz Rodrigues (Guarda, Portugal)

Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Session: COVID-19 and management of lung cancer
Session type: E-poster
Number: 3853

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Da Silva Arana Fonseca Ribeiro (Guarda, Portugal), G. Samouco (Guarda, Portugal), R. Martins Natal (Guarda, Portugal), S. Braga (Guarda, Portugal), F. Luís (Guarda, Portugal), L. Ferreira (Guarda, Portugal), R. Matos Gomes (Guarda, Portugal), L. Vaz Rodrigues (Guarda, Portugal). Evolution in the diagnostic approach to lung cancer. 3853

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Complexity of diagnostics of complicated lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 39s
Year: 2004

An algorithm for lung cancer staging
Source: School Course 2014- Endoscopic ultrasound in the diagnosing and staging of lung cancer
Year: 2014


Mediastinal staging in lung cancer: A rational approach
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Modern staging in lung cancer: from the current multidisciplinary process to novel approaches
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Modern profiling of advanced lung cancer at the primary diagnosis and during therapy
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018


Screening and diagnosis of lung cancer
Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer
Year: 2013


The ALA/ATS implementation guide on lung cancer screening
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018


Possibility of noninvasive differential diagnostics of lung tuberculosis and lung cancer in oncologic hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 160s
Year: 2003

Our diagnostic time for lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 322s
Year: 2005

Feasibility of bronchial washing fluid-based approach to early-stage lung cancer diagnosis
Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer
Year: 2019



Evolution in the pathological study of lung cancer
Source: Virtual Congress 2020 – Management issues in thoracic oncology
Year: 2020


Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018

Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012